A Dutch study is currently evaluating Lutetium-177 (a radiolabeled prostate-specific membrane antigen (PSMA)-binding small molecule) given initial findings that 90% of ACC expresses PSMA with positive uptake on PSMA-focused PET scans. Here, FOLH1 is linked to adrenal cortex carcinoma.